Could a once-weekly shot replace insulin for kids with thalassemia-related diabetes?
NCT ID NCT07370922
First seen Feb 01, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study tested whether a GLP-1 receptor agonist (a type of diabetes drug) works better than insulin for managing diabetes in children aged 10-18 with transfusion-dependent thalassemia. 80 participants received either the GLP-1 drug or standard insulin therapy. The main goal was to see if blood sugar control improved over 6 months using continuous glucose monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSFUSION DEPENDENT BETA THALASSEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of medicine, Ain Shams University
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.